.png)
Engineered in Europe.
Built for the Gulf.
European pharmaceutical engineering expertise, mapped to Gulf regulatory frameworks. Damgaard Group serves manufacturers across the GCC with European standards and Gulf-ready operations.
Saudi Vision 2030 demands European partners.
The Gulf pharmaceutical market is building. SFDA alignment and GCC regulatory fluency separate capable partners from credible ones. Damgaard Group operates with the European standards that regulators expect, including EU GMP Annex 1, ISPE GAMP 5, and pharmacopoeial frameworks recognized worldwide.
We support owners and EPCM firms across the GCC with vendor-neutral engineering, validation expertise, and the documentation rigor that inspection-ready facilities require.
Active across six GCC markets.
Pharmaceutical engineering capability mapped to each market's regulatory requirements.
Saudi Arabia
UAE
Qatar
Kuwait
Bahrain
Oman
Two foundations of credible Gulf delivery.
Regulatory alignment
SFDA, MOHAP, MOPH, NHRA frameworks mapped to FDA and EMA expectations. Our work translates European GMP requirements into the documentation and validation evidence Gulf regulators recognize.
Market reach and presence
We partner with owners and EPCM firms across the GCC. English documentation standard. Senior engineers available for site visits, technical reviews, and confidential conceptual studies.
What we deliver in the Gulf.
Five core engineering disciplines, applied with European rigor across pharmaceutical manufacturing facilities.
Aseptic processing and containment
Isolators, RABS, VHP bio-decontamination strategies, aseptic fill-finish lines, and cleaning validation.
Sterilization and washing systems
Autoclaves, depyrogenation tunnels, GMP washers for utensils and components, freeze dryers, cycle design and qualification.
Utilities and cleanrooms
HVAC, WFI, Clean Steam, CIP/SIP, ISO 14644 environmental monitoring, sampling, and validation.
Robotics and automation
Collaborative robotics, AGVs and AMRs, line integration, safety systems, IT/OT/PLC/SCADA integration.
CSV/CSA and data integrity
Risk-based validation per GAMP 5, 21 CFR Part 11 compliance, audit trail requirements, inspection readiness.
Owner's engineer support
Vendor-neutral selection, FAT/SAT, DQ/IQ/OQ/PQ qualification, technology transfers, structured training programs.
How we work with Gulf clients.
A staged methodology that aligns with how Gulf pharmaceutical projects are scoped, validated, and inspected.
Discovery and gap mapping
Rapid workshops to define scope, constraints, and a compliance map aligned to EU GMP, SFDA, and FDA requirements.
Concept and design
Layouts, URS/FS/DQ packages, vendor RFQ and evaluation with clear compliance requirements built in from day one.
Execution
Owner's engineer or procurement support, factory and site acceptance tests, commissioning, and risk management.
Qualification and validation
Risk-based qualification (IQ/OQ/PQ), data integrity, and inspection readiness for SFDA and other GCC authorities.
Handover and training
SOPs, English documentation, on-site training, and performance monitoring beyond project close.
Who we serve.
Pharmaceutical manufacturers across the most regulated and complex segments.
Start a confidential conversation.
Tell us about your project. We respond within one business day.
Based in Birkerød, near Copenhagen. Senior engineers available for Gulf site visits, technical reviews, and conceptual studies.
All Gulf project enquiries handled with full confidentiality. NDA available on request.
We support clients in achieving compliance with FDA, EMA, SFDA expectations and leading pharmacopoeias. Damgaard Group does not claim agency over regulatory approvals.
Damgaard Group is the shared name of Damgård Solutions ApS and Catalyst Reactivate ApS. GMP engineering and H₂O₂ catalyst reactivation for pharmaceutical manufacturers, and hospital sterilizer revalidation through Valideringseksperterne.